News

Posted on October 5, 2014

SOM BIOTECH AT 2ND IRDIRC CONFERENCE FOCUSED ON RARE DISEASES.

Posted on September 17, 2014

Mr. Raj Airey, new strategic advisor to the board of directors

Posted on September 5, 2014

MR. RAJ AIREY, NEW STRATEGIC ADVISOR TO THE BOARD OF DIRECTORS

Posted on July 5, 2014

SOM BIOTECH OBTAINS THE APPROVAL FROM REGULATORY AUTHORITIES TO CARRY OUT THE PHASE IIA CLINICAL TRIAL FOR TTR AMYLOIDOSIS

Posted on June 5, 2014

SOM BIOTECH AT BIO INTERNATIONAL CONVENTION 2014

Posted on April 17, 2014

Clinical Phase II of SOM0226 for transthyretin amyloidosis

Posted on April 5, 2014

4TH INTERNATIONAL MEETING OF PEOPLE AFFECTED BY ALS

Posted on March 5, 2014

SOM BIOTECH AT BIO-EUROPE SPRING 2014

Posted on January 17, 2014

Orphan drug designation for SOM0226

Posted on October 5, 2013

SOM BIOTECH WINS ENTREPRENEURXXI PRIZE